ARTICLE | Company News
KSB, Aurelium in proteomics deal
February 20, 2001 8:00 AM UTC
KS Biomedix (LSE:KSB) and Aurelium BioPharma will develop protein therapeutics to treat multi-drug resistant cancer. Aurelium will provide protein targets expressed on tumour cells that are resistant ...